Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …

Background The duration and effectiveness of immunity from infection with and vaccination
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to …

Between 7 and 25 May, 86 monkeypox cases were confirmed in the United Kingdom (UK).
Only one case is known to have travelled to a monkeypox virus (MPXV) endemic country. …

Background BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have
been rapidly rolled out in the UK from December, 2020. We aimed to determine the factors …

The emerging pathogen Candida auris has been associated with nosocomial outbreaks on
five continents. Genetic analysis indicates the simultaneous emergence of separate clades …

Background Candida auris is an emerging and multidrug-resistant pathogen. Here we report
the epidemiology of a hospital outbreak of C. auris colonization and infection. Methods …

Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation
of routine smallpox vaccination in most countries. It is estimated that over 70% of the world…

Increases in invasive group A streptococcal (iGAS) infection and associated deaths,
particularly in children, above seasonally expected levels are being seen this season (772 …

Background The scale of the 2022 global mpox (formerly known as monkeypox) outbreak
has been unprecedented. In less than 6 months, non-endemic countries have reported more …